Omar Malik
Overview
Explore the profile of Omar Malik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
674
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Malik O, Varga M, Moussawi A, Hunt D, Szymanski B, Toroczkai Z, et al.
Phys Rev E
. 2024 Mar;
109(2-1):024113.
PMID: 38491611
To better understand the temporal characteristics and the lifetime of fluctuations in stochastic processes in networks, we investigated diffusive persistence in various graphs. Global diffusive persistence is defined as the...
2.
Malik O, Gong B, Moussawi A, Korniss G, Szymanski B
Sci Rep
. 2022 Apr;
12(1):6372.
PMID: 35430595
We study how public transportation data can inform the modeling of the spread of infectious diseases based on SIR dynamics. We present a model where public transportation data is used...
3.
Nicholas R, Rhone E, Mariottini A, Silber E, Malik O, Singh-Curry V, et al.
Neurology
. 2021 Jul;
97(9):e890-e901.
PMID: 34253634
Objective: To examine outcomes in people with multiple sclerosis (PwMS) treated with autologous hematopoietic stem cell transplantation (AHSCT) in a real-world setting. Methods: This was a retrospective cohort study of...
4.
Harris L, Hateley S, Baheerathan A, Malik O
Cureus
. 2021 Mar;
13(2):e13411.
PMID: 33758706
We report a case of a previously well, 25-year-old Caucasian female whose diagnosis of multiple sclerosis (MS) followed significant trauma. Her symptoms and signs developed quickly and satisfied the criteria...
5.
Sovetkina A, Nadir R, Scalfari A, Tona F, Murphy K, Rigoni E, et al.
J Clin Endocrinol Metab
. 2020 Jul;
105(9).
PMID: 32667988
Context: Alemtuzumab is an anti-CD52 monoclonal antibody used in the treatment of relapsing-remitting multiple sclerosis (MS). Between 20% and 40% of alemtuzumab-treated MS patients develop autoimmune thyroid disease (AITD) as...
6.
Kolanko M, Win Z, Patel N, Malik O, Carswell C, Gontsarova A, et al.
J Neurol
. 2020 Jun;
267(11):3268-3273.
PMID: 32556533
Background: Cognitive dysfunction affects 40-60% of individuals with multiple sclerosis (MS). The neuropsychological profile commonly consists of a subcortical pattern of deficits, although a proportion of patients have a severe...
7.
Steer P, Nader A, Ostler A, Malik O, Prior R, Scurr J
Comput Methods Programs Biomed
. 2019 Aug;
182:105046.
PMID: 31470220
Objective: To audit routine clinical practice in screening patients admitted to an accident and emergency department for deep venous thrombosis in the leg (DVT) and compare it with a computer...
8.
Malik O, Saleh S, Suleiman B, Ashqar B, Maibam A, Yaseen M, et al.
Transplant Proc
. 2019 Aug;
51(6):1801-1809.
PMID: 31399166
BK viremia (BKV) is a recognized and potentially serious problem in renal transplantation. The risk factors and the impact of BKV on renal allograft and patient survival are controversial. This...
9.
Yaseen M, Hassan W, Awad R, Ashqar B, Neyra J, Heister T, et al.
Kidney Dis (Basel)
. 2019 Apr;
5(2):69-80.
PMID: 31019921
Background: Although renal replacement therapy prevents death from uremia, survival among patients with acute and chronic kidney diseases (CKD) remains an imperative concern. The expected life span of US dialysis...
10.
Mehra V, Rhone E, Widya S, Zuckerman M, Potter V, Raj K, et al.
Clin Infect Dis
. 2019 Apr;
69(10):1757-1763.
PMID: 30980715
Introduction: Autologous hematopoietic stem cell transplantation (AHSCT) with anti-thymocyte globulin (ATG) conditioning as treatment of active multiple sclerosis (MS) is rapidly increasing across Europe (EBMT registry data 2017). Clinically significant...